FILTRIX Logo FILTRIX Find Your Edge →

Latest signal:

MREO Stock Analysis

Data source: Trade-Ideas Alerts | 46 alerts analyzed | Backtest period: 2022-03-30 → 2024-08-05

⚠️ Small sample size (46 alerts). Statistics may have high variance. Interpret with caution.

🏢 Company Profile

Mereo BioPharma Group plc American Depositary Shares PHARMACEUTICAL PREPARATIONS (SIC 2834)
📍 NASDAQ 📅 IPO: Apr 24, 2018 🔗 www.mereobiopharma.com
💰 Market Cap: $83.9M 👥 Employees: 36
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
📊
46
Total Alerts
🎯
58.7%
Win Rate (EOD)
💰
+0.63%
Avg Gain (EOD)
🚀
+7.83%
Avg MFE (Max Potential)

📈 Performance by Timeframe

5MIN

Win Rate: 34.8%
Avg Gain: -0.41%
Avg Winner: +1.97%
Avg Loser: -2.01%
Best: +7.82%
Worst: -6.00%
Trades: 16/25

15MIN

Win Rate: 26.7%
Avg Gain: -1.06%
Avg Winner: +3.69%
Avg Loser: -3.07%
Best: +13.22%
Worst: -10.14%
Trades: 12/30

30MIN

Win Rate: 39.1%
Avg Gain: -0.85%
Avg Winner: +3.78%
Avg Loser: -4.29%
Best: +11.76%
Worst: -13.38%
Trades: 18/25

60MIN

Win Rate: 30.4%
Avg Gain: -1.61%
Avg Winner: +4.82%
Avg Loser: -4.42%
Best: +11.76%
Worst: -13.81%
Trades: 14/32

EOD (End of Day)

Win Rate: 58.7%
Avg Gain: +0.63%
Avg Winner: +6.84%
Avg Loser: -8.20%
Best: +16.99%
Worst: -31.05%
Trades: 27/19

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +7.83%
Best MFE: +30.58%
Avg Time to MFE: 143 min

On average, MREO alerts reach +7.83% profit potential within 143 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -3.36%
Worst MAE: -12.95%
Avg Time to MAE: 22 min

Before reaching MFE, expect an average drawdown of 3.36%.

⚖️ Risk/Reward Ratio

2.33:1

Excellent risk/reward - potential gain is 2.33x the typical drawdown.

💡 Trading Insight: Based on 46 alerts, MREO typically reaches +7.83% profit before pulling back. Consider setting profit targets around 6.3% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 46
Gap Up % 41.3%
Avg Gap -0.13%
Best Gap +4.74%

🏭 Sector Comparison: PHARMACEUTICAL PREPARATIONS

How MREO compares to 381 other tickers in the same sector.

5-Min Gain
MREO: -0.46% Sector: -0.32% -0.14%
EOD Gain
MREO: +0.75% Sector: +4480411.22% -4480410.47%
Avg MFE
MREO: +7.92% Sector: +7.56% +0.36%

📋 Last 20 Alerts

Historical MREO alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2024-08-05 09:27:00 $3.5 +0.86% +0.14% +5.14% +4.43% +11.43% +12.00% -4.29% -0.29% WIN
2024-07-02 09:27:03 $3.63 - - +1.24% +0.28% -4.96% +3.58% -0.96% -0.55% -
2024-06-14 09:27:38 $4.01 +4.11% +4.86% +4.74% +4.61% +5.99% +9.98% -0.50% -0.25% WIN
2024-06-12 09:27:54 $3.94 +0.76% +3.30% +5.54% -3.55% -2.79% +6.09% -2.28% - WIN
2023-10-18 09:25:00 $1.8 +0.56% - +2.12% +5.56% +7.22% +13.89% -1.67% +0.56% WIN
2023-10-17 09:27:00 $1.53 +7.82% +7.19% +11.76% +11.76% +16.99% +19.61% +0.65% +0.65% WIN
2023-10-16 09:28:00 $1.52 -1.32% -0.81% -1.32% +1.32% +5.26% +15.13% -3.95% -1.32% LOSS
2023-08-23 09:25:00 $1.35 +0.01% -3.71% -5.56% -0.73% +3.70% +7.41% -5.87% - WIN
2023-07-03 09:27:00 $1.3 - +1.42% -0.81% -0.77% -0.77% +2.31% - +2.31% -
2023-06-23 09:27:00 $1.29 - +1.55% +1.55% -0.39% +0.78% +2.25% -0.78% +1.55% -
2023-06-09 09:28:00 $1.37 -3.28% -0.78% -0.36% -2.55% -2.92% +0.73% -4.38% - LOSS
2023-06-07 09:25:00 $1.12 +1.76% +4.02% +7.14% +8.04% +10.71% +21.43% +0.89% +0.89% WIN
2023-06-06 09:28:00 $1.17 -0.43% -0.85% -5.98% -6.06% -1.71% +0.85% -0.85% -1.71% LOSS
2023-05-18 09:26:00 $1.35 -1.48% -0.01% +1.48% -2.25% -7.41% +2.96% -2.96% -2.96% LOSS
2023-05-02 09:29:00 $1.25 -1.20% -2.00% -3.20% -3.60% -4.00% - -2.40% -0.80% LOSS
2023-04-18 09:25:00 $1.06 -1.89% -0.97% -3.77% -4.31% +5.66% +6.60% -5.66% -1.89% LOSS
2023-04-10 09:25:00 $0.89 -3.71% -0.56% -1.71% -3.97% +1.92% +2.71% -7.34% +1.69% LOSS
2023-03-21 09:26:00 $0.85 -0.19% -4.41% -0.59% -2.47% +1.76% +3.51% -9.55% -1.18% LOSS
2023-02-13 09:27:00 $1.09 -1.83% -5.50% -3.67% -6.42% -4.59% +2.75% - - LOSS
2022-10-17 09:25:00 $1.05 +1.90% - +1.08% -2.86% -4.76% +3.81% - +0.95% WIN

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

🚀 Beat the 58.7% Baseline on MREO

The 58.7% win rate is just the raw starting point. Launch the app to apply filters (Volume, RSI, Time) and see if you can push MREO's performance to 75%+.

Optimize MREO Strategy →

Why Analyze MREO with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for MREO. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, MREO historically offers an average upside of +7.83% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 MREO Momentum Personality

With a baseline win rate of 58.7%, MREO shows neutral behavior, suggesting the need for additional volume confirmation.

⏱️ Optimized Exit Timing

Don't guess when to sell. Our backtests show MREO performs best on the EOD (End of Day) timeframe (Avg Gain: +0.63%), signaling that gains often fade later in the session.